VEGETATIVE DISORDERS IN PARKINSON S DISEASE

Similar documents
ROLE AND IMPORTANCE OF REHABILITATION TREATMENT IN PATIENTS WITH PARKINSON S DISEASE VODA, Ioana¹; DOGARU, Gabriela¹, ²

III./3.1. Movement disorders with akinetic rigid symptoms

Evaluation of Parkinson s Patients and Primary Care Providers

Multiple choice questions: ANSWERS

Optimizing Clinical Communication in Parkinson s Disease:

Pa t h w a y s. Pa r k i n s o n s. MacMahon D.G. Thomas S. Fletcher P. Lee M. 2006

The clinical diagnosis of Parkinson s disease rests on

Non-motor symptoms in Thai Parkinson s disease patients: Prevalence and associated factors

Program Highlights. Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone Medical Center New York, New York

The PD You Don t See: Cognitive and Non-motor Symptoms

DIFFERENTIAL DIAGNOSIS SARAH MARRINAN

The Latest Research in Parkinson s Disease. Lawrence Elmer, MD, PhD Professor, Dept. of Neurology University of Toledo

10th Medicine Review Course st July Prakash Kumar

Non-motor subtypes of Early Parkinson Disease in the Parkinson s Progression Markers Initiative

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee

The PD You Don t See: Cognitive and Non-motor Symptoms

Evaluation of non-motor symptoms in Parkinson s Disease: An underestimated necessity

Premotor PD: autonomic failure

FOUNDATION OF UNDERSTANDING PARKINSON S DISEASE

Parkinson s Disease. Sirilak yimcharoen

WHAT DEFINES YOPD? HANDLING UNIQUE CONCERNS REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA MARCH 14, 2019

Parkinson s Disease. Patients will ask you. 8/14/2015. Objectives

PARKINS ON CENTER. Parkinson s Disease: Diagnosis and Management. Learning Objectives: Recognition of PD OHSU. Disclosure Information

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Assistant Professor of Neurology

Parkinson s Disease WHERE HAVE WE BEEN, WHERE ARE WE HEADING? CHARLECE HUGHES D.O.

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Associate Professor of Neurology

Motor Fluctuations in Parkinson s Disease

Presented by Meagan Koepnick, Josh McDonald, Abby Narayan, Jared Szabo Mentored by Dr. Doorn

MAXIMIZING FUNCTION IN PARKINSON S DISEASE

Non-motor symptoms as a marker of. Michael Samuel

Parkinson s Disease Update

10/13/2017. Disclosures. Deep Brain Stimulation in the Treatment of Movement Disorders. Deep Brain Stimulation: Objectives.

Parkinson s Disease in the Elderly A Physicians perspective. Dr John Coyle

Parkinson s Disease Current Treatment Options

Non-Motor Symptoms of Parkinson s Disease

Parkinson s Disease Associated Sleep Disturbance Ehsan M. Hadi, MD, MPH. Dignity Health Neurological Institute

Comprehensive Approach to DLB Management

Parkinson s Disease Psychosis Treatment in Long-Term Care: Clinical and Operational Considerations

Chemical Control of Behavior and Brain 1 of 9

Vague Neurological Disorders

Parkinson s Disease Update. Presented by Joanna O Leary, MD Movement disorder neurologist Providence St. Vincent s

United Council for Neurologic Subspecialties Geriatric Neurology Written Examination Content Outline

Autonomic Nervous System Testing Creating Central Balance

UPDATE ON RESEARCH IN PARKINSON S DISEASE

Behavioral Aspects of Parkinson s Disease

Parkinson s Disease Initial Clinical and Diagnostic Evaluation. J. Timothy Greenamyre, MD, PhD

INCREASING FUNCTIONALITY AND THE QUALITY OF LIFE THROUGH MEDICAL REHABILITATION IN PATIENTS WITH PARKINSON S DISEASE

Parkinson s Disease: initial diagnosis, initial treatment & non-motor features. J. Timothy Greenamyre, MD, PhD

Depression and Anxiety in Parkinson s Disease. Bill Collins Symposium for Parkinson s Disease 2018 Robert Underwood, Ph.D. Licensed Psychologist

T. Laitinen Departments of Physiology and Clinical Physiology, University of Kuopio and Kuopio University Hospital, Kuopio, Finland

8/28/2017. Behind the Scenes of Parkinson s Disease

Parkinson s Disease. Gillian Sare

MIGRAINE A MYSTERY HEADACHE

Identification number: TÁMOP /1/A

Središnja medicinska knjižnica

Faculty. Joseph Friedman, MD

Parkinson s disease (PD) is a common and complex

First described by James Parkinson in his classic 1817 monograph, "An Essay on the Shaking Palsy"

Prior Authorization with Quantity Limit Program Summary

Headway Victoria Epilepsy and Parkinson s Centre

Evaluation and Management of Parkinson s Disease in the Older Patient

ORTHOSTATIC INTOLERANCE AN EXPRESSION OF AUTONOMIC DISFUNCTION IN PARKINSON S DISEASE

How to Diagnose Early (Prodromal) Lewy Body Dementia. Ian McKeith MD, FRCPsych, F Med Sci.

Classes of Neurotransmitters. Neurotransmitters

Psychiatric aspects of Parkinson s disease an update

Welcome and Introductions

Clinical aspects of pterin disorders

Parkinson s disease. Quick reference guide. Issue date: June Diagnosis and management in primary and secondary care

Parkinson's Disease KP Update

Canadian Guidelines on Parkinson s Disease Executive Summary

M. Carranza M. R. Snyder J. Davenport Shaw T. A. Zesiewicz. Parkinson s Disease. A Guide to Medical Treatment

VL VA BASAL GANGLIA. FUNCTIONAl COMPONENTS. Function Component Deficits Start/initiation Basal Ganglia Spontan movements

symptoms of Parkinson s disease EXCEPT.

Prodromal symptoms and early detection of Parkinson s disease in general practice: a nested case-control study

European Commission approves ONGENTYS (opicapone) a novel treatment for Parkinson s disease patients with motor fluctuations

Behavioral Issues in Dementia. March 27, 2014 Dylan Wint, M.D.

Mastering Your Anxiety in Parkinson s Disease

Surgical Treatment for Movement Disorders

Welcome and Introductions

With Time, The Pathology of PD Spreads Throughout the Brain

Summary. Neuro-urodynamics. The bladder cycle. and voiding. 14/12/2015. Neural control of the LUT Initial assessment Urodynamics

6/13/2017 PROFESSOR CHRISTOPHER J MATHIAS. Non-motor features in PD AUTONOMIC NERVOUS SYSTEM. Motor. Non-Motor CLINICAL AUTONOMIC MANIFESTATIONS

POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) IT S NOT THAT SIMPLE

Treatment of Parkinson s Disease: Present and Future

American Board of Physical Medicine & Rehabilitation. Part I Curriculum & Weights

:{ic0fp'16. Geriatric Medicine: Blood Pressure Monitoring in the Elderly. Terrie Ginsberg, DO, FACOI

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

PLEASE DO NOT WRITE ON THE TEST. ONLY WRITE ON THE ANSWER SHEET

Any interventions, where RCTs in PD are not available, are not included in the tables.

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits

Parkinson s Foundation

Review Article Nonmotor Symptoms in Parkinson s Disease in 2012: Relevant Clinical Aspects

Early Clinical Features of Parkinson s Disease and Related Disorders. Dr. Alastair Noyce

Depression & Anxiety. What can I do? What are other possible treatments? What is this? Why does this happen? KEY POINTS

Faculty Disclosure. Sanjay P. Singh, MD, FAAN. Dr. Singh has listed an affiliation with: Consultant Sun Pharma Speaker s Bureau Lundbeck, Sunovion

Published in the Russian Federation European Journal of Medicine. Series B Has been issued since ISSN: Vol. 2, Is. 1, pp.

#CHAIR2016. September 15 17, 2016 The Biltmore Hotel Miami, FL. Sponsored by

Movement Disorders- Parkinson s Disease. Fahed Saada, MD March 8 th, th Family Medicine Refresher Course St.

Autonomic nervous system dysfunction in Parkinson s disease patients

Transcription:

VEGETATIVE DISORDERS IN PARKINSON S DISEASE LILIANA CUIBUS 1, M. PEREANU 1 PhD candidate Lucian Blaga of Sibiu, Lucian Blaga University of Sibiu Keywords: Parkinson's disease, motor symptoms, premotor or prodromal Cuvinte cheie: boala Parkinson, simptome motorii, fază premotorie sau prodromală Abstract: Parkinson's disease therapeutic strategies must be directed to both the motor (nigra) symptoms and to non-motor extranigral signs. In the last decade, it has been proven that non-motor symptoms precede long before the first motor signs of the Parkinson's disease, causing the so-called prodromal or premotor. The premotor is associated with the discomfort caused by the autonomous dysfunction, sleep disturbances, sensory dysfunction, neuropsychiatric disorders, fatigue and restless leg syndrome. Rezumat: Strategiile terapeutice din boala Parkinson trebuie să fie îndreptate atât asupra simptomelor motorii (nigrale), cât şi non-motorii extranigrale. În ultimii zece ani s-a dovedit ca simptomele nonmotorii preced cu mult înainte primele semne motorii din boala Parkinson, determinând aşa-numita fază premotorie sau prodromală. Faza premotorie este asociată cu disconfortul determinat de disfuncţia autonomă, tulburările de somn, disfuncţia senzorială, tulburările neuropsihiatrice, oboseală şi sindromul picioarelor neliniştite. INTRODUCTION Parkinson s disease is a neurodegenerative disorder with evolution to a progressive aggravation corresponding to the dopaminergic neuronal loss from the black substance (substantia nigra). The neuronal loss at the moment of the clinical symptomatology occurrence is of 6%.(1) Parkinson s disease is the second neurodegenerative disease in terms of frequency after the Alzheimer s disease. The motor symptoms are associated with non-motor symptoms from the incipient s of the disease. PURPOSE The purpose of the article is to evaluate the non-motor symptoms in the patients with Parkinson s disease. Table no 1. The non-motor symptoms in the Parkinson s disease () Parkinson s disease Other non-motor symptoms: sleep disorders olfactory dysfunction pain Psychiatric symptoms: depression panic attack hallucination dementia Vegetative symptoms: sweat symptoms digestive symptoms orthostatic hypotension genito-urinary disorders hypersalivation q Digestive system dysfunction a) Constipation - The literature data distinguishes the presence of constipation in 55% of the cases with Parkinson s disease; - The activity of the colonic smooth musculature is controlled by the intrinsic enteric neurons together with the sympathetic extrinsic neurons inhibitors or parasympathetic exciting neurons.(3) b) Sialorrhea - The data from the literature mentions its presence in more than 7% of the patients with Parkinson s disease. c) Dysphagia: Dysphagia is also frequently met, especially in the off periods.(4) q Urogenital dysfunction - Nicturia is the most precocious sign of autonomic dysfunction (5); - It is often followed by the increase of the mictional frequency, of imperious mictions and difficulties with miction; - Those problems are determined by the detrusor hyperreflexia or by the absence or incomplete relaxation of the muscles of the pelvic wall. q Sexual dysfunction - Is a common problem of the patients with Parkinson's disease; - It appears as a precocious manifestation of the dysfunction of the autonomic nervous system; Hypersexuality was reported, especially, in the patients under dopamine agonists treatment.(6) q The cardio-vascular autonomic dysfunction - Orthostatic hypertension appears most frequently in the late s of the Parkinson's disease (7); - The decrease of the systolic arterial pressure with more than mm Hg and of the diastolic arterial pressure with more than 1mm Hg occurs after 15 minutes of dorsal decubitus position when turning to orthostatism (5 minutes). q The disorders of thermoregulation and sweating - In more than 64% of the patients with Parkinson's disease, an increase of sweating at the head, face, trunk, neck level was observed, which is a compensatory reaction at the decrease of the sympathetic activity in extremities; - The neurochemical and anatomical basis of those disorders are unknown.(8) 1 Corresponding author: Liliana Cuibus, Str. St. O. Iosif 1B, Sibiu, e-mail: cuibusliliana@yahoo.com, tel: +4 744683 Article received on 8.1.11 and accepted for publication on 15..1 ACTA MEDICA TRANSILVANICA June 1;():13-134 AMT, v. II, no., 1, p. 13

METHODS The study included a number of patients from the specialty ambulatory and from the department of neurology within the Clinical County Hospital of Sibiu; The period of patients inclusion in the study was December 7-June 11; The age of the patients was 55-75 years old; The degree of smell and pain impairment was evaluated on visual and analogue scales (severe, medium, mild). A. The inclusion criteria: - The patients with a positive diagnosis of Parkinson s disease on the basis of the neurological exams and of the paraclinical investigations; - The patients in different s of evolution according to the Hoehn-Yahr classification: the I st unilateral impairment; the II nd unilateral impairment without postural disorders; the III rd bilateral impairment with minor postural lack of balance (the patient has a normal life); the IV th bilateral impairment with postural instability (the patient needs support in performing the daily activities). - Cranial CT exam normal. B. The exclusion criteria: - The patients suffering from type I, II of diabetes mellitus due to the possibilities of false positive results; - The patients with Parkinson s disease, Hoehn-Yahr V th ; - The patients with associated cardiovascular, genitourinary and digestive disorders; - The patients under 55 years or over 75 years old. RESULTS Table no.. Stages repartition according to gender IV th III th I st, II nd Fe 4 1 66 Males 6 3 84 Table no. 3. Stages distribution according to the age group IV th III rd I st, II nd Fe 17 61 Males 8 3 89 Table no. 4. Repartition on gender and age groups of the studied batch 55-65 years old 66-75 years old Males 44 76 Fe 36 44 Figure no. 3. The repartition on gender and age groups of the studied batch: Constipation: Table no. 5. Gender and disease repartition IV th 4 3 III th 11 14 I st, II nd 11 17 Figure no. 4. Gender and disease repartition female s Figure no. 1. Stages repartition according to gender Table no. 6. Disease s repartition according to the presence of the constipation Presence Absence IV th 7 3 III rd 5 15 I st, II nd 8 1 Figure no.. Stages distribution according to the age group Figure no. 5. Disease s reparation according to the presence of the constipation 14 1 1 8 6 4 prezentă absentă absentă prezentă AMT, v. II, no., 1, p. 131

Sexual disorders: Table no. 7. Disease and gender repartition IV th 7 III th 4 5 I st, II nd Figure no. 6. Disease and gender repartition Table no. 1. Disease s repartition according to the presence of urinary disorders Presence Absence IV th 8 III rd 38 I st, II nd 54 96 Figure no. 9. Disease s repartition according to the presence of urinary disorders 5 1 8 6 96 15 1 5 Femei fe 4 8 38 54 Stadiu IV Stadiu III Stadiu I,II Table no. 8. Disease s repartition according to the presence of the sexual disorders Presence Absence IV th 9 1 III th 9 31 I st, II nd 18 Sweating disorders: Table no. 11. Disease and gender repartition IV th 3 4 III th 9 15 I st, II nd 4 35 Figure no. 1. Disease and gender repartition 6 5 4 3 Femei fe 1 Urinary disorders: Table no. 9. Disease and gender repartition IV th 4 4 III th 17 1 I st, II nd 9 45 Table no. 1. Disease s repartition according to the Nocturnal Daily Absent IV th 5 3 III th 11 13 16 I st, II nd 44 15 91 Figure no. 11. Disease s repartition according to the Figure no. 8. Disease and gender repartition 6 5 4 3 Femei fe 1 1% 9% 8% 7% 6% 5% 4% 3% % 1% % nocturne diurne Stadiu IV Stadiu III Stadiu I,II Salivation disorders: AMT, v. II, no., 1, p. 13

Table no. 13. Disease and gender repartition IV th 3 III rd 7 11 I st, II nd 15 7 Figure no. 1. Disease and gender repartition Table no. 16. Disease s repartition according to the presence of the dysphagia Permanent Intermittent Absent IV th 5 3 III th 4 6 3 I st, II nd 1 11 138 Figure no. 15. Disease s repartition according to the presence of the dysphagia Table no. 14. Disease repartition according to the presence of salivation disorders Permanent Intermitten Absent t IV th 1 4 5 III th 3 15 I st, II nd 1 41 18 Figure no. 13. Disease repartition according to the 1% 9% 8% 7% 6% 5% 4% 3% % 1% % Dysphagia: permanente intermitente Table no. 15. Disease and gender repartition IV th 4 4 III rd 5 5 I st, II nd 4 8 Figure no. 14. Disease and gender repartition 1% 9% 8% 7% 6% 5% 4% 3% % 1% % permanentă intermitentă absentă Cardiovascular disorders: Table no. 17. Disease and gender repartition IV th 3 III th I st, II nd Figure no. 16. Disease and gender repartition 5 4,5 4 3,5 3,5 1,5 1,5 Bărbaţi Femei fe Table no. 18. Repartition on disease s according to the presence of cardiovascular disorders Present Absent IV th 5 5 III th 4 I st, II nd 15 Figure no. 17. Disease s repartition according to the presence of cardiovascular disorders 1 1 8 6 4 Bărbaţi Femei fe 18 16 14 1 1 8 6 4 AMT, v. II, no., 1, p. 133

Table no. 19. Repartition of the presence of sexual and urinary disorders according to the disease Sexual disorders Urinary disorders Present Absent Present Absent IV th 9 1 8 III th 9 31 38 I st, II nd 18 54 96 6. Hussain IF, Brady CM, Swinn MJ, et al. Treatments of erectile dysfunction with sildenafil citrate in parkinsonism duet o Parkinson s Disease with observation on orthostatic hypotension. J Neurol Neurosurg Psychiatry. ;7:681. 7. Schulmann LM, Tabock RL, Bean J, Weiner WJ. Comorbidity of the non-motor symptoms of Parkinson s Disease. Mov Disord. 1;16:57-51. 8. Wolters E. Variability in the clinical expression of Parkinson s Disease. J Neurol Neurosurg Psychiatry. 8;65:197-3. Figure no. 18. Repartition of the presence of the sexual and urinary disorders according to the disease 1% 8% 6% 4% % tulburări urinare tulburări urinare tulburări sexuale tulburări sexuale % CONCLUSIONS - The majority of the patients who presented smell disorders also had associated constipation; - The patients with sexual disorders from different evolution s also had urinary disorders; - The sweat disorders were present in an important proportion among those with salivation disorders; - Orthostatic hypotension was identified in a small number of patients only in the IV th of disease; - The constipation was present in 3% of the patients, the literature data presented a percentage of 8-61%; - Dysphagia, sweating and salivation disorders were present in small percentages regarding the data from literature; - None of the studied patients presents all the sensitive - sensory and autonomic disorders; - Due to the fact that there are smell disorders, pain, constipation, gastro-intestinal disorders, sweat disorders even from the I st of the disease, we may assert that the nonmotor symptoms have existed before establishing the diagnosis of Parkinson s disease; - All the non-motor studied signs have a significant impact on the quality of life of the patients with Parkinson's disease. REFERENCES 1. Abbot RD, Petrowitch H, White LR, et al. Frequency of bowel movement and the future risk of Parkinson s Disease. Neurology. 1;57:456-46.. Jankovic J, Tolosa E. Parkinson s Disease & Movement Disorders. V- edition. Chapter 5:7-74. 3. Goetz CG, Lutge W, Tanner CM. Autonomic dysfunction in Parkinson s disease. Neurology. 1986;36:73-75. 4. Witjas T, Kaphan E, Azulay JP, Blin O, Ceccaldi M, Pouget J, et al. Nonmotor fluctuations in Parkinson s disease: frequent and disabling. Neurology. ;13(59):48-413. 5. Wolters EC. Non-motor extranigral signs and symptoms in Parkinson s disease. Parkinsonism Relat Disord. 9;15Suppl 3:S6-1. AMT, v. II, no., 1, p. 134